Diabetic Retinopathy News and Research

RSS
In the initial stages, people with diabetic retinopathy may not notice their vision changing. Diabetics sometimes experience rapid changes in blood sugar that can temporarily cause blurry vision even when retinopathy is not present. If a person notices a few specks or spots floating in his visual field, this may mean he has developed proliferative diabetic retinopathy, the growth of abnormal new blood vessels on the retina and optic nerve. High blood sugar levels have been linked in studies to retinal blood vessel abnormalities. Blurred vision may occur when the macula--the small area at the center of the retina--swells as it fills with fluid that has leaked from retinal blood vessels. Because damage to the eye often develops slowly, early detection of diabetes and control of blood sugar through diet and medications can make a crucial difference in saving vision.

Effective diabetic retinopathy treatments include laser photocoagulation for early to moderate stages and a microsurgery called vitrectomy for repair of eyes with extensive damage. Injectable and oral medications that act on abnormal blood vessels to control diabetic retinopathy before vision loss occurs are now in development. Early detection would be key to the effectiveness of these treatments, also.
Minocycline fails to slow vision loss in people with dry age-related macular degeneration

Minocycline fails to slow vision loss in people with dry age-related macular degeneration

Study reveals TDP-43 protein's key role in blood vessel formation and integrity

Study reveals TDP-43 protein's key role in blood vessel formation and integrity

Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema

Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema

Red light exposure mitigates blood glucose spikes after meals

Red light exposure mitigates blood glucose spikes after meals

Red light therapy lowers blood sugar and mitigates glucose spikes

Red light therapy lowers blood sugar and mitigates glucose spikes

Breakthrough $20 million OCT project aims to revolutionize eye health screening

Breakthrough $20 million OCT project aims to revolutionize eye health screening

New treatment targeting aging cells could offer lasting relief for diabetic macular edema

New treatment targeting aging cells could offer lasting relief for diabetic macular edema

Groundbreaking technology shows immense potential for treating ischemic retinopathy

Groundbreaking technology shows immense potential for treating ischemic retinopathy

Innovative diabetes detection method with DiaNet v2, utilizing retinal imaging technology

Innovative diabetes detection method with DiaNet v2, utilizing retinal imaging technology

AI exam boosts diabetic eye screening rates in youth

AI exam boosts diabetic eye screening rates in youth

Can AI predict diabetic eye disease progression?

Can AI predict diabetic eye disease progression?

Targeted ocular spectroscopy shines new light on retinal health

Targeted ocular spectroscopy shines new light on retinal health

AI in healthcare: A double-edged sword? Study reveals impact on diagnostic accuracy

AI in healthcare: A double-edged sword? Study reveals impact on diagnostic accuracy

Study identifies key factor in lung and eye damage in preemies

Study identifies key factor in lung and eye damage in preemies

Exonate announces successful completion of Phase Ib/IIa trial in diabetic macular oedema

Exonate announces successful completion of Phase Ib/IIa trial in diabetic macular oedema

Researchers develop state-of-the-art UV protective contact lenses

Researchers develop state-of-the-art UV protective contact lenses

A new framework for evaluating AI in health care: Moving beyond tool performance

A new framework for evaluating AI in health care: Moving beyond tool performance

Falk Trust awards $1.35 million to Case Western Reserve researchers for cancer and diabetic retinopathy treatments

Falk Trust awards $1.35 million to Case Western Reserve researchers for cancer and diabetic retinopathy treatments

Citrus compounds show zesty promise in type 2 diabetes management

Citrus compounds show zesty promise in type 2 diabetes management

Study: Extending diabetic eye screen to 2 years could risk critical treatment delays and sight loss

Study: Extending diabetic eye screen to 2 years could risk critical treatment delays and sight loss

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.